Clinical Trial Update: Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports a phase 2/3 long-term safety and tolerability study of givinostat for Duchenne muscular dystrophy, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Givinostat (givinostat)

Snippet

Sponsor: Italfarmaco | Conditions: Duchenne Muscular Dystrophy | Phase 2, Phase 3 | Status: RECRUITING